Showing results (151-160 of 259) with videos related to

Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2021
BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 ExpressionLijie Xing, Su Wang, Jiye Liu, et al.
Scientific Reports|November 26, 2020
Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironmentLanting Liu, Zhen Yu, Hui Cheng, et al.
Cancers|January 10, 2026
Two Decades of Real-World Study in Newly Diagnosed Multiple Myeloma: Evolving Treatment and Outcomes in China with Reference to the United StatesJingyu Xu, Meng Shu, Hsingwen Chung, et al.
Scientific Reports|April 15, 2025
Clinical characteristics and treatment response of chronic disseminated candidiasis in patients with hematological disordersZhangjie Chen, Sisi Zhen, Jiali Sun, et al.
Oncotarget|November 9, 2016
Mutations or copy number losses of CD58 and TP53 genes in diffuse large B cell lymphoma are independent unfavorable prognostic factorsYang Cao, Tao Zhu, Peiling Zhang, et al.
Haematologica|May 30, 2024
LILRB4 represents a promising target for immunotherapy by dual targeting tumor cells and myeloid-derived suppressive cells in multiple myelomaLixin Gong, Hao Sun, Lanting Liu, et al.
Oncotarget|October 31, 2015
High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survivalShuhua Yi, Dehui Zou, Chengwen Li, et al.
Oncogenesis|March 7, 2020
Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1sMeirong Zang, Jiaojiao Guo, Lanting Liu, et al.
Oncotarget|September 30, 2015
Detection of recurrent cytogenetic aberrations in multiple myeloma: a comparison between MLPA and iFISHMeirong Zang, Dehui Zou, Zhen Yu, et al.
Medscience|June 2, 2026
Obinutuzumab plus bendamustine as first-line therapy for indolent B-cell lymphomas: a prospective multicenter open-label studyYuting Yan, Xinyang Hu, Xiuhua Sun, et al.
Pageof 26